He is the lead author of a book titled Linear Mixed Models: A Practical Guide using Statistical Software, Third Edition, which compares different statistical software packages in terms of their mixed-effects modeling procedures, and is also the co-author of Applied Survey Data Analysis, among other books.

[1] His work has been featured in media outlets such as The New York Times,[11] The Wall Street Journal,[12] and The Michigan Daily.

Carlos A. Coelho called its first edition "A very good starting point for those willing to get a more in-depth knowledge of LMMs",[14] and Petra Macaskill applauded the authors "for undertaking—and to a large extent succeeding in—such an ambitious project.

Katherine Jenny Thompson, in her review of this work, said, "As an overview of quantitative research applied to survey methodology, the book is a success.

"[19] Additionally, he co-edited Interviewer Effects from a Total Survey Error Perspective, published in 2020, examining interviewer roles, challenges, and solutions within survey data collection, with a focus on training, management, analysis, and data quality optimization through the TSE framework.

"[20] West's applied research has examined substance use, mental health, and discrimination among diverse U.S. populations, revealing heightened risks for certain sexual orientation groups,[21] increased odds of substance use disorders for LGBT adults experiencing discrimination,[22] and complex relationships between sexual orientation, race/ethnicity, and gender with mental health disorders.

[23] He has also highlighted disparities in depression care utilization across ethnic and racial groups,[24] and elevated substance use disorder risks among sexual minorities due to childhood victimization.

In particular, his work has brought to light the importance of prevention efforts targeting children and adolescents,[26] the crucial role of continued monitoring in guiding prevention and intervention efforts,[27] the need for enhanced vigilance in prescribing and monitoring opioids among adolescents,[28] and national trends in medical and nonmedical use of prescription opioids among US high school seniors.

[30] In related research, he was involved in a study that underscored improved survival rates with the ipilimumab-radiotherapy combination in melanoma brain metastases, highlighting the significance of multimodality therapy for achieving better outcomes.